High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study
NCT ID: NCT05740839
Last Updated: 2025-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-12-04
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The names of the study interventions involved in this study are/is:
* High-Intensity Interval Training (HIIT)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fitness to Aid the Brain and Cognitive Skills
NCT05367076
The Neuro-protective Effects of Exercise in Children With Brain Tumors
NCT01944761
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer
NCT03223753
Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors, the StepByStep Study
NCT04089358
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors
NCT07215091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized (selected at random) for two groups: HIIT program group will complete a 16-week intervention period followed by a 16-week period with no intervention and the waitlisted control group will complete a 16-week period and will perform their usual, daily activities followed by an optional 16-week period in which they can complete the HIIT program.
Research procedures include screening for eligibility, study treatment including in-clinic evaluations of fitness and strength, blood collection, at-home zoom exercise sessions, self-administered activity logs, and survey questionnaires.
Participation in this research study is expected to last about 8 months.
It is expected that about 30 people will take part in this research study.
The Stahl Family Charitable Foundation, Pedal 4 Pediatrics, and the Childhood Brain Tumor Foundation are supporting this research study by providing funding for the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIIT Exercise Program Group
Participants will be randomly assigned to the HIIT exercise group and receive:
* 3x weekly for 16 week home-based virtually supervised High-Intensity Interval Training.
* 16-week self-directed exercise follow up period.
* 3 On-site visits at Week 1, 18 and 34 for assement testing and completion of questionnaires
HIIT Exercise Program
Exercise program with stationary bike via the Zoom platform.
Control Group
Participants will be randomly assigned to the HIIT waitlist control group and receive:
* Daily usual activities
* 2 On-site visits at Week 1, and 18 for assement testing and completion of questionnaires
* Option to complete 16 week, 3x weekly HIIT exercise program after initial 16 week period.
Control Group
Usual Activities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HIIT Exercise Program
Exercise program with stationary bike via the Zoom platform.
Control Group
Usual Activities
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At time of study are a young adult, aged 18-39 years.
* Histologically diagnosed brain tumor during childhood (diagnosed ≤18 years).
* Are at least 2 years post tumor-directed therapy.
* The effects of exercise on the developing fetus are unknown. For this reason, women of child-bearing potential must agree to undergo a pregnancy test and to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation. Should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately.
* Medically cleared to participate in exercise by their referred physician or a certified clinical exercise physiologist.
* Are without medical conditions that could exacerbate with exercise, such as bone disease (excluding bone metastases) at imminent risk of fracture or uncontrolled cardiopulmonary or metabolic diseases.
* Speak English and/or Spanish.
* Currently participate in less than or equal to 60 minutes of moderate or vigorous structured exercise/week.
* Does not smoke or vape (no smoking/vaping during previous 12 months).
* Willing to travel to DFCI for necessary data collection.
* Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria
* Pre-existing medical conditions such as uncontrolled cardiopulmonary disease, or metabolic diseases that could exacerbate with exercise.
* Patients with active malignancies.
* Patients who are pregnant.
* Actively on a weight loss diet.
* Participate in more than 60 minutes of moderate or vigorous structured exercise/week.
* Currently smokes or vapes.
* Unable to travel to DFCI for necessary data collection.
* May not be able to comply with the safety monitoring requirements of the study in the opinion of the investigator.
18 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stahl Family Charitable Foundation
UNKNOWN
The Childhood Brain Tumor Foundation
UNKNOWN
Pedals For Pediatrics
UNKNOWN
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christina Dieli-Conwright, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christina Dieli-Conwright, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
PhD, MPH
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.